CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Role of Predictive Genomics in Sustainable Healthcare

Role of Predictive Genomics in...

Bridging the Diversity Gap in Genomics

Bridging the Diversity Gap in Genomics

Parse Biosciences and Research Instruments Group have announced a partnership to offer RNA-Seq kits in Singapore and Southeast Asia.

Parse Biosciences and Research...

The Value of New Antibiotics in the Fight Against AMR

The Value of New Antibiotics in the...

Improving Minimal Residual Disease Detection Using NGS

Improving Minimal Residual Disease...

Multiomic Preclinical Models to Define the Mechanism of Action

Multiomic Preclinical Models to...

Developing Patient-Centric Precision Oncology Therapies: Begin With The End In Mind

Developing Patient-Centric Precision...

What the New EMA Draft

What the New EMA Draft "Guideline on...

Role of Predictive Genomics in Sustainable Healthcare

Role of Predictive Genomics in...

Bridging the Diversity Gap in Genomics

Bridging the Diversity Gap in Genomics

Parse Biosciences and Research Instruments Group have announced a partnership to offer RNA-Seq kits in Singapore and Southeast Asia.

Parse Biosciences and Research...

The Value of New Antibiotics in the Fight Against AMR

The Value of New Antibiotics in the...

Improving Minimal Residual Disease Detection Using NGS

Improving Minimal Residual Disease...

Multiomic Preclinical Models to Define the Mechanism of Action

Multiomic Preclinical Models to...

Developing Patient-Centric Precision Oncology Therapies: Begin With The End In Mind

Developing Patient-Centric Precision...

What the New EMA Draft

What the New EMA Draft "Guideline on...

The Growing Significance of Genomics Technology

Life Sciences Review | Wednesday, June 01, 2022
Tweet

COVID-19 pandemic, an incomparable global public health emergency affected almost every industry, and its long-term effects have impacted the growth of genomics industry too. Genomics is a branch of biotechnology associated with using genetics and molecular biology techniques for the genetic mapping and DNA sequencing of sets of genes or entire genomes of selected organisms, storing the results in databases, and putting the data to use (as in medicine or biology). The major factors that have contributed to the growth of the genomics market over the years are growing government support and increased genomics research, lowered sequencing costs, and increased genomics applications.


The increasing number of start-up enterprises and medical genetics in developing countries is primarily responsible for the market's growth. Rising demand for genomes for medical applications, on the other hand, is expected to boost the growth of the Asia Pacific genomics market in the coming years. From US$ 3.2 billion in 2017, the Asia Pacific genomics industry is predicted to grow to US$ 7.6 billion in 2025. From 2018 to 2025, the market is expected to develop at a CAGR of 10.6 percent.


The healthcare professionals in the Asia Pacific region were unprepared for the requirements of clinical genetic services and have struggled to cope with both, communicable and non-communicable diseases. 


The need for genetic services has risen due to a mix of demands from the middle class population and a lack of regulatory control. Even within the same geographic region, the variety and pattern of genetic illnesses in emerging countries vary. Hence, the focus is on prevention of diseases through carrier screening, genetic counseling and prenatal diagnosis. As a result, the Ministry of Health & Family Welfare has initiated newborn screening programs for sickle cell disease in select states, with intentions to expand it to additional areas.


In 2017, the sequencing segment held a largest market share of 38.1 percent of the genomics market. Due to increased use of genomics sequencing technologies, this category is likely to dominate the market in 2025. Furthermore, the microarray segment is expected to develop at the fastest rate from 2018 to 2025. Additionally, during the forecast period of 2018 to 2025, the services category is expected to develop significantly. During the forecast period, the diagnostics segment is expected to increase at a CAGR of 12.0 percent by application. Diagnostics benefit humans in preventing diseases from being passed down to their children, as well as providing clarity for more concise treatment.


Some of the major primary and secondary sources for genomics included in the report are, Association for Responsible Research and Innovation in Genomics (ARRIGE), Biotechnology Industry Research Assistance Council (BIRAC), Defense Advanced Research Projects Agency (DARPA), Department of Biotechnology (DBT), Ministry of Health and Prevention (Mohap), and among others.


 


Weekly Brief

loading
Top 10 Genomics Solutions Companies in APAC – 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

The Importance of Technology in Multinational Clinical Research

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/the-growing-significance-of-genomics-technology--nwid-673.html